Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.018 | 0.8 |
mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.014 | 0.8 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.025 | 0.8 |
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.8 |